Literature DB >> 24485949

Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.

Weilian Yang1, Rolf F Barth2, Tianyao Huo1, George W Kabalka3, Aarif L Shaikh3, Syed A Haider4, Subhash Chandra4.   

Abstract

The present study was undertaken to evaluate the effects of l-DOPA pre-loading on the uptake of BPA using the F98 rat glioma and the murine B16 melanoma models. In vitro pretreatments of F98 glioma and B16 melanoma cells with l-DOPA, followed by exposure to BPA increased boron uptake, as determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES). Based on this, in vivo studies were initiated in F98 glioma bearing rats. Initially, the l-DOPA dosing paradigm was evaluated. Maximum tumor boron uptake was observed following i.p. administration of l-DOPA (50mg/kg) followed 24h later by BPA (31.8±8.9 vs. 17.2±6.3µg/g for BPA alone). Next, the effect of l-DOPA pre-loading as a function of the route of administration of BPA was evaluated in F98 glioma bearing rats. The greatest increase in uptake was seen following i.v. administration of BPA, while in contrast no significant increase was seen following intracarotid (i.c.) administration (38.6±12.4 vs. 34.2±10.9). Cellular localization of the F98 glioma, as determined by secondary ion mass spectrometry (SIMS) boron imaging revealed equivalent tumor boron concentrations following l-DOPA pre-loading. In vivo studies in B16 melanoma bearing mice showed equivalent tumor boron values in treated and untreated mice, suggesting that the effects of l-DOPA pre-loading may depend both on the histologic type of tumor and its anatomic site.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B16 murine melanoma; Boronophenylalanine; F98 rat glioma; SIMS; l-DOPA pre-loading

Mesh:

Substances:

Year:  2014        PMID: 24485949      PMCID: PMC4048765          DOI: 10.1016/j.apradiso.2014.01.002

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  14 in total

1.  Subcellular imaging by dynamic SIMS ion microscopy.

Authors:  S Chandra; D R Smith; G H Morrison
Journal:  Anal Chem       Date:  2000-02-01       Impact factor: 6.986

2.  Quantitative imaging of boron, calcium, magnesium, potassium, and sodium distributions in cultured cells with ion microscopy.

Authors:  W A Ausserer; Y C Ling; S Chandra; G H Morrison
Journal:  Anal Chem       Date:  1989-12-15       Impact factor: 6.986

3.  Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.

Authors:  R F Barth; W Yang; J H Rotaru; M L Moeschberger; D D Joel; M M Nawrocky; J H Goodman; A H Soloway
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

4.  Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.

Authors:  W Yang; R F Barth; R T Bartus; J H Rotaru; M L Moeschberger; A K Ferketich; M M Nawrocky; J A Coderre; J H Goodman
Journal:  Neurosurgery       Date:  2000-07       Impact factor: 4.654

5.  Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.

Authors:  R F Barth; W Yang; J H Rotaru; M L Moeschberger; C P Boesel; A H Soloway; D D Joel; M M Nawrocky; K Ono; J H Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-04-01       Impact factor: 7.038

6.  Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy.

Authors:  D R Smith; S Chandra; J A Coderre; G H Morrison
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

7.  Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.

Authors:  K Z Matalka; M Q Bailey; R F Barth; A E Staubus; A H Soloway; M L Moeschberger; J A Coderre; E K Rofstad
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

8.  A nude rat model for neutron capture therapy of human intracerebral melanoma.

Authors:  R F Barth; K Z Matalka; M Q Bailey; A E Staubus; A H Soloway; M L Moeschberger; J A Coderre; E K Rofstad
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-03-30       Impact factor: 7.038

9.  L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.

Authors:  Silvia Capuani; Tommaso Gili; Marco Bozzali; Salvatore Russo; Paola Porcari; Cesare Cametti; Emanuela D'Amore; Marco Colasanti; Giorgio Venturini; Bruno Maraviglia; Giuseppe Lazzarino; Francesco S Pastore
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

10.  Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.

Authors:  Subhash Chandra; Rolf F Barth; Syed A Haider; Weilian Yang; Tianyao Huo; Aarif L Shaikh; George W Kabalka
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

View more
  2 in total

1.  Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.

Authors:  Subhash Chandra; Rolf F Barth; Syed A Haider; Weilian Yang; Tianyao Huo; Aarif L Shaikh; George W Kabalka
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

2.  Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism.

Authors:  Takahiro Nomoto; Yukiya Inoue; Ying Yao; Minoru Suzuki; Kaito Kanamori; Hiroyasu Takemoto; Makoto Matsui; Keishiro Tomoda; Nobuhiro Nishiyama
Journal:  Sci Adv       Date:  2020-01-22       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.